KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Share-based Compensation (2016 - 2025)

Exact Sciences (EXAS) has disclosed Share-based Compensation for 16 consecutive years, with $55.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 13.09% to $55.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $217.7 million, a 1.29% increase, with the full-year FY2025 number at $217.7 million, up 1.29% from a year prior.
  • Share-based Compensation was $55.6 million for Q4 2025 at Exact Sciences, up from $51.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $77.3 million in Q1 2021 to a low of $45.9 million in Q4 2022.
  • A 5-year average of $56.2 million and a median of $55.8 million in 2021 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 161.47% in 2021, then crashed 32.15% in 2022.
  • Exact Sciences' Share-based Compensation stood at $55.9 million in 2021, then dropped by 17.83% to $45.9 million in 2022, then grew by 27.57% to $58.6 million in 2023, then dropped by 16.0% to $49.2 million in 2024, then increased by 13.09% to $55.6 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Share-based Compensation are $55.6 million (Q4 2025), $51.6 million (Q3 2025), and $55.8 million (Q2 2025).